Factors associated with the use of cannabis for self-medication by adults : data from the French TEMPO cohort study
© 2024. The Author(s)..
BACKGROUND: Medical cannabis, legalized in many countries, remains illegal in France. Despite an experiment in the medical use of cannabis that began in March 2021 in France, little is known about the factors associated with the use of cannabis for self-medication among adults.
METHODS: Data came from the French TEMPO cohort and were collected between December 2020 and May 2021. Overall, 345 participants aged 27-47 were included. Cannabis for self-medication was defined using the following questions: 'Why do you use cannabis?' and 'In what form do you use cannabis?'. The penalized regression method "Elastic net" was used to determine factors associated with the use of cannabis for self-medication, with the hypothesis that it is mainly used for pain in individuals who have already used cannabis.
RESULTS: More than half of the participants reported having ever used cannabis (58%). Only 10% used it for self-declared medical reasons (n = 36). All self-medication cannabis users, except one, were also using cannabis for recreational purposes. The main factors associated with cannabis use for self-medication vs. other reasons included cannabis use trajectories, the presence of musculoskeletal disorders, tobacco smoking, and parental divorce.
CONCLUSIONS: Engaging in cannabis use during adolescence or early adulthood may increase the likelihood of resorting to self-medication in adulthood. Due to the propensity of individuals with cannabis use during adolescence to resort to uncontrolled products for self-medication, this population should be more systematically targeted and screened for symptoms and comorbidities that may be associated with cannabis use.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
Journal of cannabis research - 6(2024), 1 vom: 10. Apr., Seite 19 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wallez, Solène [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adults |
|---|
| Anmerkungen: |
Date Revised 25.04.2024 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1186/s42238-024-00230-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370899172 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370899172 | ||
| 003 | DE-627 | ||
| 005 | 20240425233807.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240411s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s42238-024-00230-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1386.xml |
| 035 | |a (DE-627)NLM370899172 | ||
| 035 | |a (NLM)38600591 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wallez, Solène |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Factors associated with the use of cannabis for self-medication by adults |b data from the French TEMPO cohort study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.04.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a BACKGROUND: Medical cannabis, legalized in many countries, remains illegal in France. Despite an experiment in the medical use of cannabis that began in March 2021 in France, little is known about the factors associated with the use of cannabis for self-medication among adults | ||
| 520 | |a METHODS: Data came from the French TEMPO cohort and were collected between December 2020 and May 2021. Overall, 345 participants aged 27-47 were included. Cannabis for self-medication was defined using the following questions: 'Why do you use cannabis?' and 'In what form do you use cannabis?'. The penalized regression method "Elastic net" was used to determine factors associated with the use of cannabis for self-medication, with the hypothesis that it is mainly used for pain in individuals who have already used cannabis | ||
| 520 | |a RESULTS: More than half of the participants reported having ever used cannabis (58%). Only 10% used it for self-declared medical reasons (n = 36). All self-medication cannabis users, except one, were also using cannabis for recreational purposes. The main factors associated with cannabis use for self-medication vs. other reasons included cannabis use trajectories, the presence of musculoskeletal disorders, tobacco smoking, and parental divorce | ||
| 520 | |a CONCLUSIONS: Engaging in cannabis use during adolescence or early adulthood may increase the likelihood of resorting to self-medication in adulthood. Due to the propensity of individuals with cannabis use during adolescence to resort to uncontrolled products for self-medication, this population should be more systematically targeted and screened for symptoms and comorbidities that may be associated with cannabis use | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Adults | |
| 650 | 4 | |a Associated factors | |
| 650 | 4 | |a Cannabis use for self-medication | |
| 650 | 4 | |a Cannabis use trajectories | |
| 650 | 4 | |a Cohort | |
| 650 | 4 | |a Marijuana | |
| 700 | 1 | |a Kousignian, Isabelle |e verfasserin |4 aut | |
| 700 | 1 | |a Hecker, Irwin |e verfasserin |4 aut | |
| 700 | 1 | |a Rezag Bara, Selma Faten |e verfasserin |4 aut | |
| 700 | 1 | |a Andersen, Astrid Juhl |e verfasserin |4 aut | |
| 700 | 1 | |a Melchior, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Cadwallader, Jean-Sébastien |e verfasserin |4 aut | |
| 700 | 1 | |a Mary-Krause, Murielle |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cannabis research |d 2019 |g 6(2024), 1 vom: 10. Apr., Seite 19 |w (DE-627)NLM314085947 |x 2522-5782 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2024 |g number:1 |g day:10 |g month:04 |g pages:19 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s42238-024-00230-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2024 |e 1 |b 10 |c 04 |h 19 | ||